If Medical Marijuana Can Help Treat The Opioid Addiction, What Will It Mean For The Whole Cannabis Industry?

Marijuana and its components continue to prove medical benefits from day-to-day. For decades, it has been a favorite subject of debate and in-depth research. Along with this, various pharmaceutical formulations for THC are released, which the U.S. Food and Drug Administration (FDA) approved.

But, have you ever imagined what it would look like for the cannabis Industry once medical marijuana proves its positive effects on the opioid addiction crisis?

Medical Marijuana: A Possible Solution to the Opioid Epidemic

The opioid epidemic is popularly known as the opioid crisis. This has been a hot issue in the media. But, the majority don’t even have a bit of an idea about it.

This opioid epidemic refers to the increasing number of deaths and hospitalizations caused by opioids. These include analogs, prescriptions, and illicit drugs. In 2016, statistics have recorded over 40,000 cases a year (http://cnw.fm/RX7Rt), which is equivalent to 115 a day. With this growing number, drug overdose now tops up as the leading cause of accidental deaths in the USA. The epidemic started to be notorious around 2010, but the factors began to crop up several years earlier.

But the real question here is, “Is marijuana the answer to this global epidemic?”

According to the head of the National Institute on Drug Abuse (http://cnw.fm/2SEr6), there is not enough evidence that marijuana deters people from opioid addiction. However, many people are holding on to the statement that medical marijuana can be part of the solution.

A study from AmericanMarijuana has revealed some significant facts based on the 19 states where medical marijuana is legal:

  1. Out of 19 states, 15 have shown a fall in opioid prescribing rate one year after the legalization of medical marijuana.
  2. Ohio had the highest fall of opioid prescribing rates among the 19 states – from 82.7 down to 63.5

NCBI states that the legalization of marijuana for medical use was associated with the 7% reduction in opioid overdose death cases (http://cnw.fm/YGQp4) in Colorado and 6% in opioid prescriptions.

Harvard Medical School also insists that opioid prescriptions will fall by 2.21 million daily doses per year (http://cnw.fm/0FcpG) upon the effectivity of medical marijuana laws. These significant cutbacks are predominantly notable for Vicodin (hydrocodone) and morphine prescriptions.

From this data, there’s still hope in medical marijuana to be a part of the solution to resolve opioid addiction.

Cannabis Industry: Under the Spotlight for the Opioid Crisis

Medical Marijuana had come a long way before it finally showed its positive effects in treating severe health conditions. However, there is still an unending discussion on which of its components is highly beneficial for the medical industry.

If researchers continue to confirm positive feedback about the effects of Marijuana on the opioid epidemic, then there is no doubt that the whole cannabis industry will benefit a lot (http://cnw.fm/3tlVq). Business innovations and profits have a big probability of going up.

The new cases of opioid addiction can be a triggering factor for manufacturers and suppliers to increase their production. Thus, we can expect increased sales, popularity, and exposure. The cannabis industry can then surpass the sales of big pharmaceutical companies who are making billions from opioids.

There is a more active opposition from the pharma industry according to Amanda Reiman, manager of marijuana law and policy at the Drug Policy Alliance. The research she conducted reveals that more and more patients are substituting cannabis for pharmaceuticals. And it is moving at a very high rate.

Opioid overdose cases have dropped roughly by 25% in states where marijuana is legalized. This data is in comparison with states that have prohibited sales of medical marijuana. This rapid decrease in opioid cases is one of the main reasons why big pharmacies are making their way to halt the legalization of this drug. They can lose about $4B a year if laws are finally approved worldwide. In fact, the Pharmaceutical Research and Manufacturers of America spent nearly $19M in 2015 to lobby it.

Apart from that, the legalization of medical marijuana might change other people’s views about this drug. We can finally break the stigma that marijuana is only used for recreational purposes. If positive results continue to show up, then there is a huge possibility for all of us to embrace the truth that marijuana is beneficial in treating various health conditions.

In the nearest future, after laws are taken into effect, medical marijuana can be a big threat to other industries that offer treatments and medications to opioid addiction.

Final Thoughts

Many marijuana-based medications have been clinically approved for use – while others are still under trial. With this progress, a new ray of light is shining among opioid crisis victims. This means that there is still a big chance for this epidemic to end.

Given the time and effort exerted for the research, it will be no surprise if one day, we are finally able to solve all the issues regarding this opioid epidemic. But for now, let us all hope for an immediate result in the tests taken to prove the effectiveness of medical marijuana for this serious condition. Plus, it is crucial to keep our minds open for such treatments.

– This article was provided by Dwight K. Blake, Editor in Chief of AmericanMarijuana.org

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.cannabisnewswire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

This article contains Third-Party Content submitted by third parties, including articles submitted through the CNW Premium Partnership Program. All opinions, statements and representations expressed by such third parties are theirs alone and do not express or represent the views and opinions of CNW or its affiliates and owners. Content created by third parties is the sole responsibility of such third parties, and CNW does not endorse, guarantee or make representations concerning the accuracy and completeness of all third-party content. You acknowledge that by CNW providing you with this internet portal that makes accessible to you the ability to view third-party content through the CNW site, CNW does not undertake any obligation to you as a reader of such content or assume any liability relating to such third-party content. CNW expressly disclaims liability relating to such third-party content. CNW and its members, affiliates, successors, assigns, officers, directors, and partners assume no responsibility or liability that may arise from the third-party content, including, but not limited to, responsibility or liability for claims for defamation, libel, slander, infringement, invasion of privacy and publicity rights, fraud, or misrepresentation, or an private right of action under the federal securities laws of the United States or common law. Notwithstanding the foregoing, CNW reserves the right to remove third-party content at any time in its sole discretion.

Archives

Select A Month
  • November 2026
  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • July 2024
  • June 2024
  • May 2024
  • April 2024
  • March 2024
  • February 2024
  • January 2024
  • December 2023
  • November 2023
  • October 2023
  • September 2023
  • August 2023
  • July 2023
  • June 2023
  • May 2023
  • April 2023
  • March 2023
  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • January 2017
  • December 2016
  • November 2016
  • September 2016
  • August 2016
  • July 2016
  • Official NewsWire Relationships

    Alternative Products Expo Benzinga Cannabis Capital Conference Cannabis Business Summit & Expo 2019 Cannabis Drinks Expo Cannabis World Congress & Business Exposition Cannexpo Marigold PR MjMicro Conference New England Cannabis Network O'Cannabiz Conference & Expo Tether BudTender Tether BudTender Appreciation Week

    CannabisNewsWire Currently Accepts

    Bitcoin

    Bitcoin

    Bitcoin Cash

    Bitcoin Cash

    Doge Coin

    Dogecoin

    Ethereum

    Ethereum

    Litecoin

    Litecoin

    USD Coin

    USD Coin

    Contact us: 512.354.7000